Zinc arginine, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight and DNA without affecting testicular function

Andrologia. 1993 Nov-Dec;25(6):369-75. doi: 10.1111/j.1439-0272.1993.tb02745.x.

Abstract

Zinc has been implicated in steroid endocrinology of the prostate gland; and 5 alpha-dihydrotestosterone (DHT) is believed to express androgenic responses in the prostate. To note the effect of neutralized zinc (zinc gluconate + arginine) on the prostate, 50 sexually mature rats, weighing 325 +/- 20 g, were divided into five groups as follows: (1) control, (2) sham, (3) castrated, and injected intraprostatically with (4) 10 mg neutralized zinc, and (5) 20 mg neutralized zinc. Results indicated significant reduction (P < 0.05) of prostate weight, 5 alpha-reductase activity, and total protein and DNA concentrations in treated prostate tissue; no significant change in weight and histological structure of testes, epididymides, and seminal vesicles; and no significant effect on progeny and blood testosterone level of treated animals. These results suggest that direct application of neutralized zinc to the prostate offers a new modality for treatment of prostatitis without affecting spermatogenesis.

MeSH terms

  • 5-alpha Reductase Inhibitors*
  • Animals
  • DNA / metabolism*
  • Epididymis / drug effects
  • Male
  • Organ Size / drug effects
  • Pregnancy
  • Prostate / anatomy & histology*
  • Prostate / drug effects
  • Prostate / metabolism
  • Proteins / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Seminal Vesicles / drug effects
  • Testis / drug effects
  • Testis / physiology*
  • Testosterone / blood
  • Zinc / pharmacology*

Substances

  • 5-alpha Reductase Inhibitors
  • Proteins
  • Testosterone
  • DNA
  • Zinc